Clinical trial
Long-Term Study of the Efficacy and Safety of Lansoprazole in the Treatment of Zollinger-Ellison and Other Acid Hypersecretors
NCT00204373 is registered in ClinicalTrials.gov with Charles Mel Wilcox, MD as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Long-Term Study of the Efficacy and Safety of Lansoprazole in the Treatment of Zollinger-Ellison and Other Acid Hypersecretors
- Lead sponsor
- Charles Mel Wilcox, MD
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- March 31, 2003
- Completion date
- December 31, 2010
- Enrollment
- 72 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.